ES8203221A1 - Procedimiento para preparar una composicion antihelmintica acuosa termicamente reversible - Google Patents
Procedimiento para preparar una composicion antihelmintica acuosa termicamente reversibleInfo
- Publication number
- ES8203221A1 ES8203221A1 ES502519A ES502519A ES8203221A1 ES 8203221 A1 ES8203221 A1 ES 8203221A1 ES 502519 A ES502519 A ES 502519A ES 502519 A ES502519 A ES 502519A ES 8203221 A1 ES8203221 A1 ES 8203221A1
- Authority
- ES
- Spain
- Prior art keywords
- imidazo
- thiazole
- anthelmintic
- relates
- gel compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
PROCEDIMIENTO PARA PREPARAR UNA COMPOSICION ANTIHELMINTICA ACUOSA TERMICAMENTE REVERSIBLE. CONSISTE EN DISOLVER POR UNA PARTE DE 3 A 15 POR 100 EN PESO DE UNA SAL DEL COMPUESTO ANTIHELMINTICO DE FORMA GENERAL (I), O SUS ISOMEROS OPTICOS; 1,5 POR 100 EN PESO DE ACIDO CITRICO Y 1 POR 100 EN PESO DE AGUA, Y POR OTRA PARTE SE PREPARA UNA DISOLUCION DE 0,5 A 1,5 POR 100 EN PESO DE ALCOHOL BENCILICO EN 14-25 POR 100 EN PESO DE PROPILENGLICOL. SE COMBINAN AMBAS SOLUCIONES Y SE AÑADE 0,01 A 0,03 POR 100 EN PESO DE C.I. ACID YELLOW N.23; 0,01 A 0,02 POR 100 DE UN AGENTE ANTIESPUMANTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/195,532 US4287176A (en) | 1980-10-09 | 1980-10-09 | Anthelmintic levamisole and tetramisole gel compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8203221A1 true ES8203221A1 (es) | 1982-04-01 |
ES502519A0 ES502519A0 (es) | 1982-04-01 |
Family
ID=22721772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES502519A Granted ES502519A0 (es) | 1980-10-09 | 1981-05-27 | Procedimiento para preparar una composicion antihelmintica acuosa termicamente reversible |
Country Status (12)
Country | Link |
---|---|
US (1) | US4287176A (es) |
EP (1) | EP0049731B1 (es) |
JP (1) | JPS5767514A (es) |
AU (1) | AU548957B2 (es) |
CA (1) | CA1166570A (es) |
DE (1) | DE3167565D1 (es) |
DK (1) | DK166993B1 (es) |
ES (1) | ES502519A0 (es) |
HK (1) | HK81789A (es) |
NZ (1) | NZ197070A (es) |
PT (1) | PT73109B (es) |
ZA (1) | ZA813235B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56169590A (en) * | 1980-05-30 | 1981-12-26 | Jgc Corp | Continuous alcohol fermentation by immobilized yeast |
US4543358A (en) * | 1982-12-13 | 1985-09-24 | American Cyanamid Company | Anthelmintic gel composition and a method for their preparation at ambient temperatures |
EP0113397B1 (en) * | 1982-12-13 | 1989-04-19 | American Cyanamid Company | Anthelmintic gel compositions and a method for their preparation at ambient temperatures |
HU206621B (en) * | 1989-08-10 | 1992-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing veterinary compositions containing lyotrope liquide christalline benzimidazol derivative |
CN100364530C (zh) * | 2003-10-14 | 2008-01-30 | 江苏先声药物研究有限公司 | 治疗慢性鼻炎的左旋咪唑 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL180633C (nl) * | 1973-06-22 | 1900-01-01 | Bayer Ag | Werkwijze ter bereiding van een anthelmintisch werkzaam veterinair opgiet-preparaat. |
US4100271A (en) * | 1976-02-26 | 1978-07-11 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
DE2614841A1 (de) * | 1976-04-06 | 1977-10-20 | Bayer Ag | Neue pour-on-formulierungen von anthelmintika |
US4098885A (en) * | 1977-10-14 | 1978-07-04 | Zoecon Corporation | Equine anthelmintic |
-
1980
- 1980-10-09 US US06/195,532 patent/US4287176A/en not_active Expired - Lifetime
-
1981
- 1981-05-09 EP EP81103563A patent/EP0049731B1/en not_active Expired
- 1981-05-09 DE DE8181103563T patent/DE3167565D1/de not_active Expired
- 1981-05-12 DK DK210181A patent/DK166993B1/da not_active IP Right Cessation
- 1981-05-12 NZ NZ197070A patent/NZ197070A/xx unknown
- 1981-05-14 ZA ZA00813235A patent/ZA813235B/xx unknown
- 1981-05-15 AU AU70634/81A patent/AU548957B2/en not_active Ceased
- 1981-05-27 ES ES502519A patent/ES502519A0/es active Granted
- 1981-06-01 PT PT73109A patent/PT73109B/pt not_active IP Right Cessation
- 1981-06-03 CA CA000378979A patent/CA1166570A/en not_active Expired
- 1981-06-04 JP JP56085024A patent/JPS5767514A/ja active Granted
-
1989
- 1989-10-12 HK HK817/89A patent/HK81789A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK166993B1 (da) | 1993-08-16 |
EP0049731A3 (en) | 1982-09-22 |
DE3167565D1 (de) | 1985-01-17 |
NZ197070A (en) | 1983-09-02 |
CA1166570A (en) | 1984-05-01 |
JPH0136443B2 (es) | 1989-07-31 |
DK210181A (da) | 1982-04-10 |
EP0049731A2 (en) | 1982-04-21 |
JPS5767514A (en) | 1982-04-24 |
EP0049731B1 (en) | 1984-12-05 |
PT73109A (en) | 1981-07-01 |
AU548957B2 (en) | 1986-01-09 |
ZA813235B (en) | 1982-06-30 |
PT73109B (en) | 1982-09-06 |
HK81789A (en) | 1989-10-20 |
US4287176A (en) | 1981-09-01 |
ES502519A0 (es) | 1982-04-01 |
AU7063481A (en) | 1982-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8308327A1 (es) | Un procedimiento para la preparacion de nuevos derivados biciclicos de piridin-5-ona. | |
NO863061L (no) | Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater. | |
SE8402549L (sv) | Substituerade moranolinderivat | |
NO853293L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
DE69821741D1 (de) | Immunoglobulin enthaltende zusammensetzung | |
NO163776C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazoquinoksaliner. | |
NO162965C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydrotieno-(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater. | |
CS782686A2 (en) | Method of benzimidazole derivatives production | |
DE3267039D1 (en) | Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle | |
FI873672A (fi) | Kompositioner innehaollande l-3,4-dihydroxifenylalanin. | |
NO871295D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
DK0416232T3 (da) | Stabil injicerbar farmaceutisk formulering med folsyre- og leukovorinsalte og fremgangsmåde | |
ES8203221A1 (es) | Procedimiento para preparar una composicion antihelmintica acuosa termicamente reversible | |
NO863373D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater. | |
FI881040A0 (fi) | Foerfarande foer framstaellning av kristallisk cefadroxil-monohydrat. | |
DK102892A (da) | Purin-derivater, farmaceutisk praeparat omfattende forbindelserne samt forbindelser til brug som mellemprodukter | |
DK454685D0 (da) | Pyrazolo(3,4-b)-pyridinamider | |
DK407885A (da) | 7-(2-(dialkylamino)ethyl)-4-hydroxy-1,3-benzimidazol-2-oner | |
AU530678B2 (en) | Phosphono-hydroxy-acetic acid | |
DK288787A (da) | Kondenserede imidazo-heterocycliske forbindelser, fremgangsmaade til deres fremstilling, og deres anvendelse som laegemidler | |
ES2109530T3 (es) | Derivados de acidos fenil-ciclohexano-carboxilicos heterotriciclicamente sustituidos. | |
PT74949B (en) | Process for the preparation of lysin salts of acid 5-(p-chlorobenzoyl)-1,4-dymetil-pyrrol-2-acetic with analgesic activity | |
DK205682A (da) | Ringformige sulfenamider,fremgangsmaade til fremstilling derafderes anvendelse i laegemidler samt deres fremstilling | |
EP0142597A3 (en) | Curative composition for buerger's disease | |
NO166322C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970401 |